English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [2693]
News [7457]
Articles [306]
Editorials [8]
Conferences [227]
elearning [48]
MCED blood test demonstrates high specificity, strong predictive value, and...
Dr Nima Nabavizadeh - Oregon Health & Science University, Portland, USA
MCED blood test demonstrates high specificity, strong predictive value, and increased early cancer detection ( Dr Nima Nabavizadeh - Oregon Health & Science University, Portland, USA )
19 Oct 2025
Circulating tumour DNA a useful marker in CRC treatment efficacy, but only...
Dr Emerik Österlund - MD Anderson Cancer Center, Houston, USA
Circulating tumour DNA a useful marker in CRC treatment efficacy, but only alongside others ( Dr Emerik Österlund - MD Anderson Cancer Center, Houston, USA )
18 Oct 2025
Enhancing breast cancer care through AI and collaboration
Dr Gabrielle Speijer, Dr Fernando Suarez and Dr Tolga Ozmen
Enhancing breast cancer care through AI and collaboration ( Dr Gabrielle Speijer, Dr Fernando Suarez and Dr Tolga Ozmen )
9 Oct 2025
ctDNA testing improves detection of treatable metastases compared to standard...
Dr Arvind Dasari - MD Anderson Cancer Center, Houston, USA
ctDNA testing improves detection of treatable metastases compared to standard care in colorectal cancer ( Dr Arvind Dasari - MD Anderson Cancer Center, Houston, USA )
8 Oct 2025
Tumour microenvironment and circulating biomarkers predict response to...
Dr David Braun - Yale School of Medicine, New Haven, USA
Tumour microenvironment and circulating biomarkers predict response to immunotherapy in advanced RCC ( Dr David Braun - Yale School of Medicine, New Haven, USA )
2 Jun 2025
ctDNA-guided chemo escalation does not improve recurrence-free survival in...
Dr Jeanne Tie - Peter MacCallum Cancer Centre, Melbourne, Australia
ctDNA-guided chemo escalation does not improve recurrence-free survival in stage III colon cancer ( Dr Jeanne Tie - Peter MacCallum Cancer Centre, Melbourne, Australia )
2 Jun 2025
Disparities in mammogram screening amongst LGBTQ+ populations
Dr Manas Pustake - Texas Tech University Health Science Center, El Paso, USA
Disparities in mammogram screening amongst LGBTQ+ populations ( Dr Manas Pustake - Texas Tech University Health Science Center, El Paso, USA )
2 Jun 2025
AI improves accuracy in identifying HER2-low and HER2-ultralow breast cancers
Dr Marina De Brot - A.C. Camargo Cancer Center, São Paulo, Brazil
AI improves accuracy in identifying HER2-low and HER2-ultralow breast cancers ( Dr Marina De Brot - A.C. Camargo Cancer Center, São Paulo, Brazil )
2 Jun 2025
Barriers to global oncology clinical trial participation in sub-Saharan Africa
Dr Oyepeju Folashade Abioye - Allegheny Health Network, Pittsburgh, USA
Barriers to global oncology clinical trial participation in sub-Saharan Africa ( Dr Oyepeju Folashade Abioye - Allegheny Health Network, Pittsburgh, USA )
2 Jun 2025
Social determinants and survival outcomes in early-onset colorectal cancer in...
Dr Jessica Paulus - Ontada, Boston, USA
Social determinants and survival outcomes in early-onset colorectal cancer in the US ( Dr Jessica Paulus - Ontada, Boston, USA )
2 Jun 2025
Low frequency of dihydropyrimidine dehydrogenase variants in Mexican GI cancers...
Dr Enrique Soto Pérez de Celis - University of Colorado Cancer Center, Aurora...
Low frequency of dihydropyrimidine dehydrogenase variants in Mexican GI cancers should induce testing guideline reform ( Dr Enrique Soto Pérez de Celis - University of Colorado Cancer Center, Aurora, USA )
2 Jun 2025
Molecular assay may help identify NSCLC patients who could benefit from...
Dr David Spigel - Sarah Cannon Research Institute, Nashville, USA
Molecular assay may help identify NSCLC patients who could benefit from adjuvant chemotherapy ( Dr David Spigel - Sarah Cannon Research Institute, Nashville, USA )
2 Jun 2025
<123456…225>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2026 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top